UNIGE document Scientific Article - Review
previous document  unige:133032  next document
add to browser collection

Lateral lymph node dissection for rectal cancer: is it necessary?

Christou, Niki
Published in World Journal of Clinical Oncology. 2019, vol. 25, no. 31, p. 4294-4299
Abstract Rectal cancer constitutes a major public health issue according to their incidence and the number of deaths per year. Total mesorectal excision have been considered as the gold standard treatment since 1990s for mid and low rectal tumors. However, when cancer spreads to lateral lymph nodes located along the iliac and obturator arteries, Western and Japanese guidelines differ: whereas Western surgeons consider it as an advanced disease and uses neoadjuvant radiochemotherapy, Japanese surgeons define it as a local disease and proceed to lateral lymph node dissection. Herein, we review the current literature regarding both therapeutic strategies, looking for potential improvements for patients with rectal cancer.
Keywords TMETotal mesorectum excisionMesorectal resectionLLNDLateral node metastasisExtended lymphadenectomy
PMID: 31496614
Full text
Article (Published version) (371 Kb) - public document Free access
Research group Transplantation et hépatologie (905)
(ISO format)
CHRISTOU, Niki et al. Lateral lymph node dissection for rectal cancer: is it necessary?. In: World Journal of Clinical Oncology, 2019, vol. 25, n° 31, p. 4294-4299. doi: 10.3748/wjg.v25.i31.4294 https://archive-ouverte.unige.ch/unige:133032

113 hits



Deposited on : 2020-03-25

Export document
Format :
Citation style :